Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacists improve outcomes but often can’t bill for it, making billing parity key to growing services.
|Articles|August 1, 2004
The Rationale for Utilizing an Optimized Formulary to Improve the Health and Economic Outcomes of Patients with Multiple Sclerosis
The objective of this supplement is to alert managed care decision makers nationwide to how the evolution of biologics will affect both their organizations and the health and well-being of their patient populations.
Advertisement
Advertisement
Related to this article
Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacy should be treated as a clinical service line, not just a 340B financial workhorse.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicaid can't opt out of gene therapies, so planning matters more, says Katelyn Meyer, Pharm.D. | AMCP Nexus 2026
2
How common is atopic dermatitis in the US? Not nearly as common as other research has shown, according to this study
3
5 things you should know about the midterms and healthcare
4
Lower fitness tied to persistent fatty liver disease in teen boys with obesity
5